Insider trading

Period: 120 months Stock: TBPH + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

69 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

69 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

69 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

69 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
69 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
69 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

69 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Sep 2026
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan 3×
$226.79K 13,314 at 17.03
5.9%
Planned (10b5-1)
1 Jul 2026
Samaha Eli 10% owner · indirect
Sold at will
$642.63K 37,799 at 17.00
0.4%
Not planned
30 Jun 2026
Samaha Eli 10% owner · indirect
Sold at will
$428.79K 25,027 at 17.13
0.3%
Not planned
29 Jun 2026
Samaha Eli 10% owner · indirect
Sold at will
$4.72M 273,871 at 17.23
2.9%
Not planned
15 Jun 2026
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan 3×
$218.17K 13,314 at 16.39
5.4%
Planned (10b5-1)
16 Mar 2026
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan 3×
$433.64K 31,067 at 13.96
11.8%
Planned (10b5-1)
3 Dec 2025
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan 3×
$582.50K 31,067 at 18.75
10.1%
Planned (10b5-1)
26 Nov 2025
BROSHY ERAN Director
Sold on a plan 2×
$590.02K 29,501 at 20.00
39.8%
Planned (10b5-1)
11 Nov 2025
BROSHY ERAN Director
Sold at will 3×
$1.07M 59,000 at 18.11
56.1%
Sold half or more
14 Jul 2025
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan 3×
$113.87K 10,000 at 11.39
3.0%
Planned (10b5-1)
2 Jun 2025
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
$264.00K 24,000 at 11.00
6.6%
Planned (10b5-1)
21 Apr 2025
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
$36.00K 4,000 at 9.00
1.1%
Planned (10b5-1)
21 Jan 2025
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
$36.00K 4,000 at 9.00
1.3%
Planned (10b5-1)
11 Nov 2024
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold at will
$36.00K 4,000 at 9.00
1.2%
Not planned
7 Aug 2024
Samaha Eli 10% owner · indirect
Bought
$7.80M 999,800 at 7.80
11.7%
10 Jul 2024
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
$36.00K 4,000 at 9.00
1.2%
Planned (10b5-1)
1 May 2024
Samaha Eli 10% owner · indirect
Bought 2×
$13.12M 1,499,124 at 8.75
21.4%
First buy on file
22 Feb 2024
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
$10.92K 1,254 at 8.71
0.4%
Planned (10b5-1)
21 Nov 2023
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
$14.18K 1,378 at 10.29
0.4%
Planned (10b5-1)
14 Nov 2023
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold on a plan
$25.37K 2,482 at 10.22
0.7%
Planned (10b5-1)
16 Oct 2023
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold on a plan
$22.41K 2,482 at 9.03
0.7%
Planned (10b5-1)
14 Sep 2023
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold on a plan
$24.55K 2,482 at 9.89
0.7%
Planned (10b5-1)
22 Aug 2023
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
$17.11K 1,807 at 9.47
0.5%
Planned (10b5-1)
11 Aug 2023
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold on a plan
$23.20K 2,322 at 9.99
0.7%
Planned (10b5-1)
14 Jul 2023
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold at will
$22.85K 2,322 at 9.84
0.7%
Not planned
14 Jun 2023
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold at will
$24.82K 2,322 at 10.69
0.7%
Not planned
8 Jun 2023
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold at will
$19.92K 1,790 at 11.13
0.5%
Not planned
15 May 2023
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold at will
$26.15K 2,322 at 11.26
0.6%
Not planned
14 Apr 2023
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold at will
$27.60K 2,323 at 11.88
0.6%
Not planned
14 Mar 2023
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold, plan not stated
$23.97K 2,323 at 10.32
0.6%
9 Mar 2023
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold, plan not stated
$40.80K 4,000 at 10.20
1.1%
6 Mar 2023
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold, plan not stated
$23.35K 2,323 at 10.05
0.6%
14 Dec 2022
Winningham Rick E CHIEF EXECUTIVE OFFICER
Sold, plan not stated
$559.50K 50,000 at 11.19
3.6%
1 Dec 2022
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT
Sold, plan not stated
$22.36K 2,084 at 10.73
0.7%
18 Nov 2022
Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER
Sold, plan not stated
$716.24K 65,000 at 11.02
13.7%
16 Aug 2022
GRAHAM RICHARD A SVP, DEVELOPMENT
Sold, plan not stated
$47.64K 4,906 at 9.71
1.3%
9 Aug 2022
GRAHAM RICHARD A SVP, DEVELOPMENT
Sold, plan not stated
$132.61K 15,086 at 8.79
3.9%
23 May 2022
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold, plan not stated
$9.65K 1,081 at 8.93
0.3%
28 Feb 2022
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS
Sold, plan not stated
$23.95K 2,356 at 10.16
0.7%
9 Mar 2021
WORBOYS PHILIP D SVP, Research & Transl Science
Sold, plan not stated
$176.58K 8,829 at 20.00
2.5%
14 Dec 2020
GRAHAM RICHARD A SVP, Development
Sold, plan not stated
$146.06K 7,500 at 19.47
5.7%
3 Dec 2020
WORBOYS PHILIP D SVP, Research & Transl Science
Sold, plan not stated
$76.43K 4,246 at 18.00
1.3%
21 Aug 2020
HAUMANN BRETT K Chief Medical Officer
Sold, plan not stated
$457.24K 25,000 at 18.29
8.1%
20 Aug 2020
WORBOYS PHILIP D SVP, Research & Transl Science
Sold, plan not stated
$307.85K 17,103 at 18.00
4.9%
12 Dec 2019
SABESAN VIJAY SVP, Technical Operations
Sold, plan not stated
$21.60K 1,027 at 21.03
0.7%
17 May 2019
O'Connor Donal Director
Sold, plan not stated
$53.97K 2,673 at 20.19
8.8%
16 May 2019
O'Connor Donal Director
Sold, plan not stated
$27.87K 1,327 at 21.00
4.2%
5 Mar 2019
HEGDE SHARATHCHANDRA S SVP, Research
Sold, plan not stated
$139.41K 5,690 at 24.50
2.1%
4 Mar 2019
HEGDE SHARATHCHANDRA S SVP, Research
Sold, plan not stated
$83.76K 3,343 at 25.06
1.2%
12 Sep 2018
WORBOYS PHILIP D SVP, Translational Science
Sold, plan not stated
$182.20K 6,393 at 28.50
3.7%
Showing 1–50 of 69. Page 1 of 2 Older →